Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome.

Kaiser JD.

Int J Clin Exp Med. 2015 Jul 15;8(7):11064-74. eCollection 2015.

2.
3.

Does methylphenidate reduce the symptoms of chronic fatigue syndrome?

Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H.

Am J Med. 2006 Feb;119(2):167.e23-30.

PMID:
16443425
4.

Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial.

Sulheim D, Fagermoen E, Winger A, Andersen AM, Godang K, Müller F, Rowe PC, Saul JP, Skovlund E, Øie MG, Wyller VB.

JAMA Pediatr. 2014 Apr;168(4):351-60. doi: 10.1001/jamapediatrics.2013.4647.

PMID:
24493300
5.

Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.

Roerink ME, Knoop H, Bredie SJ, Heijnen M, Joosten LA, Netea MG, Dinarello CA, van der Meer JW.

Trials. 2015 Oct 5;16:439. doi: 10.1186/s13063-015-0971-z.

6.

The role of the partner and relationship satisfaction on treatment outcome in patients with chronic fatigue syndrome.

Verspaandonk J, Coenders M, Bleijenberg G, Lobbestael J, Knoop H.

Psychol Med. 2015 Aug;45(11):2345-52. doi: 10.1017/S0033291715000288. Epub 2015 Mar 3.

PMID:
25732090
7.

Plasma cytokine expression in adolescent chronic fatigue syndrome.

Wyller VB, Sørensen Ø, Sulheim D, Fagermoen E, Ueland T, Mollnes TE.

Brain Behav Immun. 2015 May;46:80-6. doi: 10.1016/j.bbi.2014.12.025. Epub 2014 Dec 31.

PMID:
25555530
8.

Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes.

Okamoto LE, Raj SR, Peltier A, Gamboa A, Shibao C, Diedrich A, Black BK, Robertson D, Biaggioni I.

Clin Sci (Lond). 2012 Feb;122(4):183-92. doi: 10.1042/CS20110200.

9.

Evidence for sensitized fatigue pathways in patients with chronic fatigue syndrome.

Staud R, Mokthech M, Price DD, Robinson ME.

Pain. 2015 Apr;156(4):750-9. doi: 10.1097/j.pain.0000000000000110.

10.

Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients.

Johnston SC, Staines DR, Marshall-Gradisnik SM.

Clin Epidemiol. 2016 May 17;8:97-107. doi: 10.2147/CLEP.S96797. eCollection 2016.

11.

The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome.

Akarsu S, Tekin L, Ay H, Carli AB, Tok F, Simşek K, Kiralp MZ.

Undersea Hyperb Med. 2013 Mar-Apr;40(2):197-200. Erratum in: Undersea Hyperb Med. 2013 May-Jun;40(3):312.

PMID:
23682549
12.

Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.

O'Dowd H, Gladwell P, Rogers CA, Hollinghurst S, Gregory A.

Health Technol Assess. 2006 Oct;10(37):iii-iv, ix-x, 1-121.

13.

Fatigue severity remains stable over time and independently associated with orthostatic symptoms in chronic fatigue syndrome: a longitudinal study.

Jones DE, Gray J, Frith J, Newton JL.

J Intern Med. 2011 Feb;269(2):182-8. doi: 10.1111/j.1365-2796.2010.02306.x. Epub 2010 Nov 14.

14.

Factors determining fatigue in the chronic fatigue syndrome: a path analysis.

Tobback E, Hanoulle I, Mariman A, Delesie L, Pevernagie D, Vogelaers D.

Acta Clin Belg. 2016 Oct;71(5):284-289. doi: 10.1080/17843286.2016.1165396. Epub 2016 May 3.

PMID:
27143625
15.

Is chronic fatigue syndrome in older patients a different disease? -- a clinical cohort study.

Lewis I, Pairman J, Spickett G, Newton JL.

Eur J Clin Invest. 2013 Mar;43(3):302-8. doi: 10.1111/eci.12046. Epub 2013 Feb 9.

PMID:
23397955
16.

Contrasting Chronic Fatigue Syndrome versus Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Jason LA, Brown A, Evans M, Sunnquist M, Newton JL.

Fatigue. 2013 Jun 1;1(3):168-183.

17.

Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome.

Lewis I, Pairman J, Spickett G, Newton JL.

J Intern Med. 2013 May;273(5):501-10. doi: 10.1111/joim.12022. Epub 2013 Jan 7.

18.

Human Placental Extract as a Subcutaneous Injection Is Effective in Chronic Fatigue Syndrome: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.

Park SB, Kim KN, Sung E, Lee SY, Shin HC.

Biol Pharm Bull. 2016 May 1;39(5):674-9. doi: 10.1248/bpb.b15-00623. Epub 2016 Feb 25.

19.

A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.

McDermott C, Richards SC, Thomas PW, Montgomery J, Lewith G.

QJM. 2006 Jul;99(7):461-8. Epub 2006 Jun 29.

PMID:
16809351
20.

Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.

Surapaneni DK, Adapa SR, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S.

J Ethnopharmacol. 2012 Aug 30;143(1):91-9. doi: 10.1016/j.jep.2012.06.002. Epub 2012 Jul 6.

PMID:
22771318

Supplemental Content

Support Center